Download Free Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Coronary Heart Disease Medical Devices Market: By Therapy, By End user, and Geography
Coronary Heart Disease Medical Devices Market: By Therapy, By End user, and Geography
Coronary Heart Disease Medical Devices Market size was valued at US$ 1.46 billion in 2022 and is poised to grow at a significant CAGR of 6.5% from 2023-2029. Coronary heart diseases allude to a narrowing of the coronary veins, the veins that supply oxygen and blood screening to the heart. It is otherwise called a coronary supply route malady. It is a noteworthy reason for ailment and demise. Coronary heart disease (CHD) regularly happens when cholesterol collects on the course dividers, making plaques. The arteries narrow, lessening the bloodstream to the heart. Now and then, coagulation can deter the stream of blood to the heart muscle. CHD generally causes angina pectoris (chest torment), shortness of breath, myocardial dead tissue, or heart attack. The coronary heart disease medical devices market is exceptionally composed and focused because of the nearness of some large, medium, and small players. Multinational merchants possess a substantial piece of the worldwide market and constantly contend with each other to pick up lion's share of partakes in the market. The focused condition in the market is relied upon to strengthen amid the conjecture time frame inferable from progress in innovation, item expansions, and expanded M&A. This report studies global coronary heart disease medical devices market dynamics elaborately to identify the current trends & drivers, future opportunities, and possible challenges to the key stakeholders operating in the market. In addition, the report includes human demographics; regulatory scenario, and competition analysis with a vividly illustrated competition dashboard to assess the market competition.
Study Period
2024-2030Base Year
2023CAGR
6.5%Largest Market
North AmericaFastest Growing Market
Europe
coronary heart disease medical devices market is driven by growing aging population who are very susceptible to the coronary heart diseases and technological develepments in coronary heart disease medical devices that minimizing the chances of infection and improved efficiency of devices. In addition, rising number of cases of heart failure and shortage of donors for late stage heart failure patients expected to boost the global coronary heart disease medical devices market during the forecast period. Furthermore, coronary heart disease medical devices are one of the more reliable and efficient options for the heart failure management. However, factors such as availability of alternative treatment options expected to hinder the market growth.
North America expected to be a major market for coronary heart disease medical devices market owing to increased demand for less invasive techniques, increase in awareness regarding available devices and increased prevalence of the cardio vascular diseases. Europe region market is expected to grow at significant rate owing to increase in cardiac disease prevalence rates. Asia Pacific region is expected to grow at faster rates due to developing healthcare infrastructure and increase in healthcare spending, funding by the governments. Especially countries such as India and China expected to have the lucrative opportunity of growth for coronary heart disease medical devices market due to increase in awareness regarding available diagnostic and treatment procedures for cardio vascular diseases and increase in medical tourism.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market Size in 2022 |
US$ 1.46 billion |
|
Market CAGR |
6.5% |
|
By Therapy |
|
|
By End User |
|
|
By Region |
|
Download Free Sample Report
The coronary heart disease medical devices market size was valued at US$ 1.46 billion in 2022.
The coronary heart disease medical devices market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
The coronary heart disease medical devices market key players are SynCardia Systems, Inc. (U.S), Medtronic (U.S), Berlin Heart GmbH (Germany), CHF Solutions, Inc. (U.S), Teleflex Incorporated (U.S), MAQUET GmbH & Co (Germany), Abiomed (U.S), Abbot Laboratories (U.S)
| 1.Executive Summary |
| 2.Global Coronary Heart Disease Medical Devices Market Introduction |
| 2.1.Global Coronary Heart Disease Medical Devices Market - Taxonomy |
| 2.2.Global Coronary Heart Disease Medical Devices Market - Definitions |
| 2.2.1.Therapy |
| 2.2.2.End User |
| 2.2.3.Region |
| 3.Global Coronary Heart Disease Medical Devices Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Coronary Heart Disease Medical Devices Market Analysis, 2018 - 2022 and Forecast 2023 - 2029 |
| 4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Coronary Heart Disease Medical Devices Market By Therapy, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 5.1. Coronary stents |
| 5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. PTCA balloon catheters |
| 5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Coronary guidewires |
| 5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6.Global Coronary Heart Disease Medical Devices Market By End User, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 6.1. Hospitals |
| 6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Ambulatory Surgical Centers |
| 6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Cardiac Centers |
| 6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 7.Global Coronary Heart Disease Medical Devices Market By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 7.1. North America |
| 7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Europe |
| 7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Asia Pacific (APAC) |
| 7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Middle East and Africa (MEA) |
| 7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Latin America |
| 7.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8.North America Coronary Heart Disease Medical Devices Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 8.1. Therapy Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.1.1.Coronary stents |
| 8.1.2.PTCA balloon catheters |
| 8.1.3.Coronary guidewires |
| 8.2. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.2.1.Hospitals |
| 8.2.2.Ambulatory Surgical Centers |
| 8.2.3.Cardiac Centers |
| 8.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.3.1.United States of America (USA) |
| 8.3.2.Canada |
| 9.Europe Coronary Heart Disease Medical Devices Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 9.1. Therapy Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Coronary stents |
| 9.1.2.PTCA balloon catheters |
| 9.1.3.Coronary guidewires |
| 9.2. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Hospitals |
| 9.2.2.Ambulatory Surgical Centers |
| 9.2.3.Cardiac Centers |
| 9.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Germany |
| 9.3.2.France |
| 9.3.3.Italy |
| 9.3.4.United Kingdom (UK) |
| 9.3.5.Spain |
| 9.3.6.Rest of EU |
| 10.Asia Pacific (APAC) Coronary Heart Disease Medical Devices Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 10.1. Therapy Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Coronary stents |
| 10.1.2.PTCA balloon catheters |
| 10.1.3.Coronary guidewires |
| 10.2. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Hospitals |
| 10.2.2.Ambulatory Surgical Centers |
| 10.2.3.Cardiac Centers |
| 10.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.China |
| 10.3.2.India |
| 10.3.3.Australia and New Zealand (ANZ) |
| 10.3.4.Japan |
| 10.3.5.Rest of APAC |
| 11.Middle East and Africa (MEA) Coronary Heart Disease Medical Devices Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 11.1. Therapy Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Coronary stents |
| 11.1.2.PTCA balloon catheters |
| 11.1.3.Coronary guidewires |
| 11.2. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Hospitals |
| 11.2.2.Ambulatory Surgical Centers |
| 11.2.3.Cardiac Centers |
| 11.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.GCC Countries |
| 11.3.2.South Africa |
| 11.3.3.Rest of MEA |
| 12.Latin America Coronary Heart Disease Medical Devices Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 12.1. Therapy Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Coronary stents |
| 12.1.2.PTCA balloon catheters |
| 12.1.3.Coronary guidewires |
| 12.2. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Hospitals |
| 12.2.2.Ambulatory Surgical Centers |
| 12.2.3.Cardiac Centers |
| 12.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Brazil |
| 12.3.2.Mexico |
| 12.3.3.Rest of LA |
| 13. Competition Landscape |
| 13.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 13.2.1.SynCardia Systems, Inc. (U.S) |
| 13.2.2.Medtronic (U.S) |
| 13.2.3.Berlin Heart GmbH (Germany) |
| 13.2.4.CHF Solutions, Inc. (U.S) |
| 13.2.5.Teleflex Incorporated (U.S) |
| 13.2.6.MAQUET GmbH & Co (Germany) |
| 13.2.7.Abiomed (U.S) |
| 13.2.8.Abbot Laboratories (U.S) |
| 14. Research Methodology |
| 15. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.